Aflac Target of Unusually High Options Trading (AFL)
Aflac (NYSE:AFL) was the recipient of some unusual options trading activity on Thursday. Investors bought 36,316 put options on the stock. This is an increase of 2,043% compared to the average daily volume of 1,695 put options.
A number of equities analysts have issued reports on AFL shares. Zacks Investment Research lowered shares of Aflac from a “buy” rating to a “hold” rating in a research report on Wednesday, March 28th. Raymond James raised shares of Aflac from an “outperform” rating to a “strong-buy” rating and raised their price target for the stock from $44.00 to $50.00 in a research report on Monday, January 22nd. Citigroup raised shares of Aflac to a “strong-buy” rating and raised their price target for the stock from $44.00 to $50.00 in a research report on Monday, January 22nd. Sandler O’Neill reissued a “hold” rating and set a $47.00 price target on shares of Aflac in a research report on Thursday, April 5th. Finally, UBS started coverage on shares of Aflac in a research report on Friday, March 2nd. They set a “neutral” rating and a $49.00 price target for the company. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating, three have issued a buy rating and two have assigned a strong buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $46.46.
In related news, Director Joseph L. Moskowitz acquired 550 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The stock was purchased at an average cost of $89.13 per share, with a total value of $49,021.50. Following the transaction, the director now directly owns 9,263 shares of the company’s stock, valued at approximately $825,611.19. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider June P. Howard sold 2,648 shares of the firm’s stock in a transaction that occurred on Wednesday, February 28th. The stock was sold at an average price of $90.33, for a total transaction of $239,193.84. The disclosure for this sale can be found here. Company insiders own 3.00% of the company’s stock.
Aflac opened at $45.53 on Friday, MarketBeat.com reports. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.22. The company has a market cap of $35.15 billion, a PE ratio of 12.56, a PEG ratio of 1.76 and a beta of 0.94. Aflac has a 1-year low of $44.95 and a 1-year high of $45.35.
Aflac (NYSE:AFL) last posted its earnings results on Wednesday, April 25th. The financial services provider reported $1.05 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.08. The firm had revenue of $5.46 billion during the quarter, compared to analyst estimates of $5.48 billion. Aflac had a net margin of 20.61% and a return on equity of 12.39%. The business’s quarterly revenue was up 2.9% on a year-over-year basis. During the same period in the previous year, the firm earned $1.47 EPS. analysts expect that Aflac will post 3.95 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, June 1st. Stockholders of record on Wednesday, May 23rd will be issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 2.28%. The ex-dividend date is Tuesday, May 22nd. Aflac’s dividend payout ratio (DPR) is 30.59%.
Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.